Recent Finacing
Recent Raise
Edge Therapeutics is a clinical-stage biopharma developing hospital-administered, Precisa polymer-based intracranial sustained‑release drug therapies (EG-1962 intraventricular nimodipine; EG-1964 for chronic subdural hematoma), in Phase 1/2.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors